PlainRecalls
FDA Drug Critical Class I Terminated

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

Reported: October 2, 2019 Initiated: September 6, 2019 #D-0125-2020

Product Description

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

Reason for Recall

Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.

Details

Recalling Firm
Darmerica, LLC
Units Affected
1.8 kilograms
Distribution
U.S.A. Nationwide
Location
Casselberry, FL

Frequently Asked Questions

What product was recalled?
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707. Recalled by Darmerica, LLC. Units affected: 1.8 kilograms.
Why was this product recalled?
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 2, 2019. Severity: Critical. Recall number: D-0125-2020.